High Patient Compliance On A Once Daily Treatment Regimen With The Hay Fever Drug Grazax

2008 ◽  
Vol 121 (2) ◽  
pp. S128-S128 ◽  
Author(s):  
I SJOLIN ◽  
L HAUGAARD ◽  
T KOPP ◽  
A JANSEN ◽  
H BRUNING ◽  
...  
Keyword(s):  
Treatment Regimen ◽  
Patient Compliance ◽  
Hay Fever ◽  
Daily Treatment ◽  
Once Daily

Once-daily treatment of psoriasis with topical glucocorticosteroid ointments

1983 ◽  
Vol 8 (4) ◽  
pp. 523-525 ◽  
Author(s):  
Alfred T. Lane ◽  
Gerald N. Wachs ◽  
William L. Weston
Keyword(s):  
Daily Treatment ◽  
Once Daily

scholarly journals Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone

2001 ◽  
Vol 15 (7) ◽  
pp. 495-498 ◽  
Author(s):  
J Pool ◽  
P Kaihlanen ◽  
G Lewis ◽  
D Ginsberg ◽  
S Oparil ◽  
...  
Keyword(s):  
Daily Treatment ◽  
Controlled Study ◽  
Once Daily

Once-Daily Treatment for Mixed Anxiety/Depressive States: A Comparison of Slow Release Amitriptyline and Fluphenazine with Nortriptyline

1977 ◽  
Vol 5 (2) ◽  
pp. 109-113 ◽  
Author(s):  
R V Magnus ◽  
A A Schiff
Keyword(s):  
Side Effects ◽  
Sustained Release ◽  
Slow Release ◽  
Anxiolytic Effect ◽  
Daily Treatment ◽  
Dry Mouth ◽  
Double Blind ◽  
Once Daily ◽  
Therapeutic Advantage ◽  
Depressive States

Patients suffering from mixed anxiety/depressive states referred to a psychiatric out-patient clinic completed a four week course of either a once-daily tablet of 30 mg nortriptyline with 1· 5 mg fluphenazine, or a sustained release capsule of 50 mg amitriptyline once daily, on a double-blind basis. Depression improved satisfactorily on either treatment, but there was a greater reduction of anxiety on fluphenazine/nortriptyline. Drowsiness, however, occurred more frequently among the patients on amitriptyline, suggesting the sedative properties of this drug did not substitute adequately for a specific anxiolytic effect. Dry mouth was also noticeably more frequent with amitriptyline. As might be expected on pharmacokinetic and physiological grounds, the results suggest that the sustained release characteristics of the amitriptyline preparation lead to a maximization of side-effects during the day without conferring any therapeutic advantage.

scholarly journals Once-a-day Tadalafil administration improves the spermogram parameters in fertile patients

2015 ◽  
Vol 87 (3) ◽  
pp. 210 ◽  
Author(s):  
Antonio Corvasce ◽  
Giuseppe Albino ◽  
Teresa Leonetti ◽  
Agnese Filomena Buonomo ◽  
Ettore Cirillo Marucco
Keyword(s):  
Seminal Fluid ◽  
Semen Quality ◽  
Type A ◽  
Daily Treatment ◽  
Sperm Cells ◽  
Average Increase ◽  
Once Daily ◽  
Positive Effects ◽  
Semen Volume

Objectives: We explored the safety of Tadalafil once-daily treatment for 12 week and its effects on semen quality in a clinical subpopulation of men with psychogenic erectile dysfunction (ED). Patients and Methods: Twenty-seven men, between 19 and 35 years, unaware of their fertility status, suffering from psychogenic ED were enrolled. The examination of the seminal fluid was performed twice before administration of Tadalafil and twice after three months of continuous daily administration of Tadalafil 5 mg. The volume of the seminal fluid, the concentration of sperm, the concentration of sperm with type “a+b” motility, the concentration of sperm with type “a” motility, the concentration of normal sperm were taken into consideration. The results before treatment with Tadalafil (T0) and after 3 months of treatment (T3m) were compared. Results: The administration of once-daily Tadalafil 5mg, brings to an average increase of the total number of sperm cells, both total and fast motility (type a) and the percentage of nemasperms, and to an average increase of semen volume of only 0.41 ml. These quantitative and qualitative improvements of the seminal fluid resulted statistically significant as regard motility, nemasperm percentage and seminal fluid volume. No unespected safety findings were observed. Conclusions: Tadalafil administration improves the quality of sperm cells and seminal fluid: in particular motility, percentage of nemasperms and volume of seminal fluid. We emphasize the safety of the once-daily treatment with tadalafil 5mg and the positive effects on spermatogenesis.

scholarly journals Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability

2020 ◽  
Vol 4 (5) ◽  
pp. s59
Author(s):  
Linda Stein Gold ◽  
David M Pariser ◽  
Marci Levy ◽  
Eric Guenin
Keyword(s):  
Acne Vulgaris ◽  
Daily Treatment ◽  
Once Daily ◽  
Severe Acne ◽  
Effect Of Age

Abstract not available.

The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection

2012 ◽  
Vol 18 (2) ◽  
pp. 241-246 ◽  
Author(s):  
Yoshihiro Yamamoto ◽  
Koichi Izumikawa ◽  
Shigeki Nakamura ◽  
Yoshifumi Imamura ◽  
Taiga Miyazaki ◽  
...  
Keyword(s):  
Daily Treatment ◽  
High Dose ◽  
Efficacy And Safety ◽  
Once Daily ◽  
Mrsa Infection

scholarly journals Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol

2019 ◽  
Vol 6 (1) ◽  
pp. e000434 ◽  
Author(s):  
Taku Nakagawa ◽  
Hiroya Hashimoto ◽  
Mitsuaki Yagi ◽  
Yoshihito Kogure ◽  
Masahiro Sekimizu ◽  
...  
Keyword(s):  
Treatment Group ◽  
Lung Disease ◽  
Treatment Regimen ◽  
Mycobacterium Avium ◽  
Drug Combination ◽  
Daily Treatment ◽  
Intermittent Treatment ◽  
Sputum Culture Conversion ◽  
Randomised Controlled ◽  
Culture Conversion

IntroductionStandard treatment for nodular/bronchiectatic Mycobacterium avium complex lung disease (NB MAC-LD), excluding severe-status cases, differs between Japan and other countries. Internationally, three-drug combination intermittent treatment (three times a week administration) with macrolide, ethambutol and rifampicin is recommended, but a daily treatment regimen is recommended in Japan. To date, no randomised controlled study directly comparing intermittent treatment with daily treatment has been performed. The purpose of this study is to investigate the usefulness of intermittent treatment.Methods and analysisA total of 140 patients diagnosed with NB MAC-LD in Japan will be randomly assigned, in a 1:1 ratio, to intermittent treatment group or daily treatment group, and three-drug combination therapy with clarithromycin, rifampicin and ethambutol will be continued for 1 year. The primary endpoint is the proportion of patients requiring modification of the initial treatment regimen. Secondary endpoints are adverse events, sputum culture conversion, time to sputum culture conversion, improvement of chest CT findings, change in health-related quality of life score and development of clarithromycin resistance.Ethics and disseminationThis trial was approved by the National Hospital Organisation Review Board for Clinical Trials (Headquarters). The results of this study will be reported at a society meeting or published in a peer-review journal.

Sign in / Sign up

Export Citation Format

Share Document